‌

US Patent 10632191 Synthetic glucopyranosyl lipid adjuvants

Patent 10632191 was granted and assigned to Infectious Disease Research Institute on April, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Infectious Disease Research Institute

Current Assignee

Infectious Disease Research Institute

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106321910

Date of Patent

April 28, 2020

Patent Application Number

157295120

Date Filed

October 10, 2017

Patent Citations Received

‌

US Patent 12077725 Ionizable cationic lipids

‌

US Patent 11591544 Ionizable cationic lipids

‌

US Patent 12064479 Lipid nanoparticles for delivery of nucleic acids and methods of use thereof

Patent Primary Examiner

‌

Traviss C Mcintosh, III

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10632191 Synthetic glucopyranosyl lipid adjuvants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API